Skip to main content
. 2025 Oct 21;11:117. doi: 10.1038/s41540-025-00590-2

Fig. 2. Anisomycin dosing scheme can enrich in specific dynamic patterns.

Fig. 2

AC Average JNK C/N ratios of cells treated with sustained (A), transient (B), or pulsed (C) anisomycin. Treated cells are shown in red versus the DMSO vehicle control in black. Thick lines represent the mean response, with shaded areas equal to the standard deviation. n is the number of cells analyzed. D Representative traces of five individual cells from each treatment and control condition. E Pulse numbers for each individual cell over the duration of the imaging. Bars shown mean ± SD. ***p < 0.001 as assessed by ANOVA. Comparisons between treated and control groups unless otherwise indicated. F Total duration of JNK activity over the 8.5-h experiment. Bars show mean ± SD. ***p < 0.001 as assessed by ANOVA. Comparisons between treated and control groups unless otherwise indicated. G Duration of JNK activity over the first 3 h. Bars show the mean ± SD. ***p < 0.001 as assessed by ANOVA. Ns = not significant. Comparisons between treated and control groups unless otherwise indicated. HJ Western blot images of phosphorylated c-Jun (pJun S73), total c-Jun, and β-actin in response to sustained (H), transient (I), or pulsed (J) anisomycin treatment confirming phosphorylation patterns of c-Jun mirror KTR traces.